Datopotamab deruxtecan Uses, Dosage, Side Effects and more
Datopotamab deruxtecan is under investigation in clinical trial NCT04656652 (Study of DS-1062A Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-LUNG01)).
Trade Name | Datopotamab deruxtecan |
Generic | Datopotamab deruxtecan |
Datopotamab deruxtecan Other Names | Datopotamab deruxtecan |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |